Patent ID: 11883421
Assignee: HUVEPHARMA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treatment of an inflammatory disease or inflammatory-related disease in a mammal comprising administering an effective amount of an anti-inflammatory compound (C) according to general formula (Ib) herein, or a pharmaceutically acceptable salt, solvate, isomer, or mixture thereof, to a mammal in need thereof, wherein the inflammatory disease or inflammatory-related disease is not driven by a microbial infection, wherein the inflammatory disease or inflammatory-related disease is a gastrointestinal inflammatory disorder selected from the group consisting of: acute gastritis, chronic gastritis, the development and recurrence of gastric ulcers, Crohn's disease, inflammatory bowel disease, irritable bowel syndrome, and ulcerative colitis, and
wherein said anti-inflammatory compound (C) acts upon inflammatory mechanisms in mammals,